Revenue segments as reported by the company.

Pharmacy revenues

Premiums

Fees and other revenues

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Pharmacy and other service costs

Medical costs and other benefit expenses

Selling, general and administrative expenses

Amortization of acquired intangible assets

Special items

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cigna

Express Scripts is a company that provides integrated pharmacy benefit management services including network-pharmacy claims processing; home delivery pharmacy services; specialty pharmacy benefit management, through its subsidiary Accredo; benefit-design consultation; drug-utilization review; formulary management; and medical and drug data analysis services to manage drug plans for health plans, self-insured employers and government agencies (both as administrator of employee benefits and public assistance programs). Express Scripts also offers pharmacy benefit management services for workers' compensation insurance programs. The program is accredited by URAC, the nation's largest accrediting body for pharmacy benefit management companies. The company processes pharmaceutical claims for members through a network of retail pharmacies. Its own automated pharmacies dispense long-term, chronic medications-like those for diabetes or heart disease-directly to members by home delivery.

Express Scripts

The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate. The Evernorth Health Services segment partners with health plans, employers, governmental organizations, and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. The Cigna Healthcare segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. The Other Operations segment consists of the remainder of business operations, which includes certain ongoing businesses and exited businesses. The Corporate segment refers to net interest expense, certain litigation matters, expense associated with frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs, and eliminations for products and services sold between segments. The company was founded in 1792 and is headquartered in Bloomfield, CT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cigna posts strong Q4 earnings, eyes growth in specialized services

Cigna delivered strong financial results in Q4 2022, with robust revenue growth and operational performance across key business segments.
While facing challenges such as margin pressures and potential disenrollment, Cigna is well-positioned to capitalize on growth opportunities in 2023.
Strategic partnerships, customer-focused strategies, and financial discipline underscore Cigna's commitment to sustainable growth and shareholder value creation.
Investments in innovation, care coordination, and market expansion signal a proactive approach to navigating industry dynamics and driving future success.

Cigna reports robust Q1 earnings, eyes growth amid challenges

Cigna's Q1 2023 showcased strong financials, growth in key segments, and increased outlook.
Challenges include economic softening impact and margin expectations for the year.
Opportunities lie in customer relationships, innovation, and market-specific strategies.
Overall, Cigna remains confident in delivering on its financial and growth targets.

Cigna reports robust Q2 results, eyes growth through innovation

Cigna's Q2 2023 performance was strong, with revenue growth, customer expansion, and technological advancements driving positive outcomes.
While facing challenges like disenrollment and risk adjustment payables, Cigna is leveraging strengths in technology and cross-selling for growth.
Opportunities lie in partnerships like VillageMD, continued innovation, and strategic bidding strategies for future growth.
Overall, Cigna remains confident in delivering on adjusted EPS outlook for 2023 and 2024, with a focus on innovation and growth.

Cigna surpasses Q3 expectations, eyes $28 EPS in 2024

Cigna's Q3 performance exceeded expectations, driven by strong revenue and EPS growth across key business segments.
Strategic focus on innovation, affordability, and client partnerships positions Cigna well for future growth and value creation.
Challenges in margin expectations and enrollment declines require proactive management and strategic decision-making.
Opportunities lie in continued growth projections, strategic investments, and enhancing healthcare affordability and accessibility.

Cigna reports robust Q4 performance, eyes growth amid strategic changes

Cigna Group's Q4 2023 Earnings Call highlighted strong financial performance, leadership changes, and strategic decisions. Analyst inquiries focused on growth drivers, market outlook, and internal healthcare spend management. The outlook for 2024 includes expectations of solid adjusted EPS, revenue growth, and operating cash flow.

Cigna surpasses Q1 expectations, eyes growth through AI and biosimilars

Cigna's Q1 performance exceeded expectations, driven by strong revenue and EPS figures.
Despite challenges like noncash losses and disruptions, Cigna's strategic strengths in AI, biosimilars, and value-based care position it well for growth.
Opportunities in AI-driven healthcare solutions, biosimilar expansions, and strategic M&A offer avenues for future growth.
Cigna's focus on precision care solutions and client outcomes showcases its commitment to innovation and efficiency.

Cigna (CI) posts robust Q2 results, eyes biosimilar growth

Cigna (CI) reports strong Q2 financial results driven by Evernorth Health Services and Express Scripts' innovative programs.
Focus on affordability, access, and behavioral health services propels growth in U.S. employer business.
Challenges include navigating healthcare cost pressures and ensuring fair pricing negotiations.
Opportunities lie in biosimilar growth, sustainable revenue outlook, and strategic Medicare Advantage business sale.

Cigna reports robust Q3 earnings, eyes growth opportunities in 2025

Cigna's Q3 earnings call highlighted strong financial performance, strategic focus on shareholder value, and challenges in specialty drugs and cost trends. The company is optimistic about opportunities in 2025 and remains committed to delivering shareholder value through strategic initiatives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Let's see if Cigna Corporation (CI) stock is a good choice for value-oriented investors right now from multiple angles.

Should Value Investors Choose Cigna Corporation (CI) Stock?

Markets with higher COVID-19 vaccination rates report better outlook on health and well-being Mental health seen as most important influence of whole person health, virtual mental health consultations increased 89 percent since beginning of pandemic Employees expect more from employers, including mental health support and workplace flexibility HONG KONG, June 16, 2021 /PRNewswire/ -- Cigna International released its seventh annual 360 Well-Being Survey with several new topics included to reveal the impact of COVID-19 on virtual health, whole person health, resilience and remote work. Opinion data from more than 18,000 adults in 21 markets across five continents confirms global pandemic recovery will require successful vaccination programs and a holistic view of supporting mental health by employers and governments.

Cigna Survey Confirms Mental Health Services and Support Critical to Global Pandemic Recovery

Anthem

UnitedHealth Group

A cheaper approach could leave more money in the pockets of patients and shareholders.

3 Stocks to Buy After Recent Changes to Medicare

Cigna, the healthcare conglomerate, acquired MDLive earlier this year, a digital platform offering virtual healthcare solutions and virtual in-home medical care.

Cigna: A Promising E-Healthcare With Strong Growth Potential

MetLife

Prudential Financial

Better pricing, product diversification and increased adoption of technology are expected to aid multiline insurers like CI, AIG, PRU, and MET.

Multiline Insurance Industry Gains 20% YTD: Stocks in Focus

Cigna (CI) looks well poised for growth on the back of its acquisitions, membership strength and other growth strategies.

Cigna (CI) Rides on Acquisitions, Strong Capital Deployment

Cigna (CI) joins forces with Oscar Health to extend its health insurance product to small business units across Arizona.

Cigna (CI), Oscar to Address Needs of Arizona's Small Businesses

Oscar Health

PHOENIX & NEW YORK--(BUSINESS WIRE)--Cigna (NYSE: CI), a global health service company, and Oscar Health, Inc. (NYSE: OSCR), the first health insurance company built on a full stack technology platform, today announced that Cigna Administered by Oscar1 small group health insurance will be available to Arizona employers across Apache, Cochise, Coconino, Gila, Graham, Greenlee, La Paz, Maricopa, Mohave, Navajo, Pima, Pinal, Santa Cruz, Yavapai, and Yuma counties starting July 1, 2021. “This pande

Cigna Administered by Oscar Expands Affordable, Innovative Health Plans for Small Businesses in Arizona

BLOOMFIELD, Conn., May 19, 2021 /PRNewswire/ -- Global health service company Cigna Corporation (NYSE:CI) announced today that Tim Wentworth, chief executive officer of Evernorth, will present at the Goldman Sachs 42nd Annual Healthcare Conference on June 9, 2021 through a virtual webcast.

Cigna Corporation Announces Appearance at the Goldman Sachs 42nd Annual Global Healthcare Conference

Humana

4 HMO Stocks in Focus as Legislative, Operating Trends Improve

CVS Health

Henry Schein

IQVIA Hlds

Medtronic

The Benzinga Global Small Cap Conference on May 13 featured presentations from publicly-traded companies and educational segments for investors. Among the featured segments was one from Chris Capre on how to trade healthcare trends.

How To Trade These 7 Healthcare Stocks and ETF Says 2ndSkiesForex's Chris Capre

Baidu

Global Payments

iShares Core MSCI Europe ETF

Raytheon Technologies

Jeremy Grantham (Trades, Portfolio), board chairman of Boston-based firm GMO, disclosed this week that his firm's top-five trades during the first quarter included a new position in Global Payments Inc. ( GPN , Financial), a boost to its stakes in Baidu Inc. ( BIDU , Financial) and Cigna Corp. ( CI , Financial) and the trimming of its holdings in Raytheon Technologies Corp. ( RTX , Financial) and iShares Core MSCI Emerging Markets ETF ( IEUR , Financial).

Jeremy Grantham's Top 5 Trades in the 1st Quarter

Centene

Molina Healthcare

Special enrollment period will be a boost to insurers??? top lines who are providing health plans on federal exchanges.

Health Insurers to Gain From Biden Open Enrollment Expansion

UnitedHealth Group, reported $4.9bn in profits in the first quarter of 2021 while CVS Health reported $2.2bn

US health insurers report billions in first quarter as small providers face stress

Cigna Corporation (CI) CEO David Cordani on Q1 2021 Results - Earnings Call Transcript

Cigna's (CI) Q1 results reflect higher pharmacy revenues, and fees and other income.

Cigna (CI) Q1 Earnings Beat Mark, Rise Y/Y on Revenue Gains

Cigna (CI) delivered earnings and revenue surprises of 7.01% and 0.84%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Cigna (CI) Tops Q1 Earnings and Revenue Estimates

Cigna Corp (NYSE: CI) reports Q1 total revenues of $41.9 billion, slightly ahead of the consensus of $40.2 billion, reflecting strong contributions from each of Cigna's ongoing businesses. Q1 Adjusted EPS of $4.73 compared with $4.69 a year ago beat the $4.38 consensus.

Cigna's Strong Performance Across Businesses Drive Q1 Earnings Beat; Raises 2021 Guidance

Shares of Cigna Corp. gained 0.5% in premarket trading Friday, after the health services company reported first-quarter profit and revenue that rose above expectations, has total customer relationships grew 14% and pharmacy customers increased 28%. Net income was $1.16 billion, or $3.30 a share, compared with $1.18 billion, or $3.15 a share, in the year-ago period.

Cigna stock gains, as profit and revenue rise above expectations

Cigna Corp on Friday raised its forecasts for full-year profit and revenue and reiterated that it anticipates a negative earnings impact of about $1.25 per share this year from COVID-19.

Health insurer Cigna raises 2021 profit, revenue forecasts

BLOOMFIELD, Conn., May 7, 2021 /PRNewswire/ -- Total revenues in the first quarter were $41.0 billion, and adjusted revenues1 were $41.0 billion Shareholders' net income for the first quarter was $1.2 billion, or $3.30 per share Adjusted income from operations2 for the first quarter was $1.7 billion, or $4.73 per share Adjusted income from operations2,3 is now projected to be at least $7.0 billion in 2021, or at least $20.20 per share3 Global health services company Cigna Corporation (NYSE: CI) today reported strong first quarter 2021 results driven by focused execution across its businesses.

Cigna Delivers Strong First Quarter 2021 Results, Raises 2021 Outlook

Expedia

Lear

McKesson

Monster Beverage

Some of the stocks that may grab investor focus today are: Wall Street expects Cigna Corp (NYSE: CI) to report quarterly earnings at $4.38 per share on revenue of $40.24 billion before the opening bell. Cigna shares rose 0.5% to $258.25 in after-hours trading.

5 Stocks To Watch For May 7, 2021

Cigna (CI) Q1 results are likely to reflect better revenues but a weak bottom line.

Cigna (CI) to Post Q1 Earnings: Will It Deliver a Beat?

Holding on to popular or trending stocks for the long-term can make your portfolio a winner.

Here's How Much a $1000 Investment in Cigna Made 10 Years Ago Would Be Worth Today

Walmart

Walmart is one of the best-positioned stocks for the trading month ahead, says Katie Stockton of Fairlead Strategies.

News for Cigna Stock (CI)